181 related articles for article (PubMed ID: 38679394)
1. Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions.
Jha SK; De Rubis G; Devkota SR; Zhang Y; Adhikari R; Jha LA; Bhattacharya K; Mehndiratta S; Gupta G; Singh SK; Panth N; Dua K; Hansbro PM; Paudel KR
Ageing Res Rev; 2024 Jun; 97():102315. PubMed ID: 38679394
[TBL] [Abstract][Full Text] [Related]
2. Cellular Senescence in Non-Small Cell Lung Cancer.
Zhu H; Sun J; Zhang C; Li P; Tan C; Yang M; Zhao G
Front Biosci (Landmark Ed); 2023 Dec; 28(12):357. PubMed ID: 38179738
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer.
Burns TF; Dobromilskaya I; Murphy SC; Gajula RP; Thiyagarajan S; Chatley SN; Aziz K; Cho YJ; Tran PT; Rudin CM
Mol Cancer Res; 2013 Apr; 11(4):329-38. PubMed ID: 23364532
[TBL] [Abstract][Full Text] [Related]
4. Membrane-Bound CD40L Promotes Senescence and Initiates Senescence-Associated Secretory Phenotype via NF-κB Activation in Lung Adenocarcinoma.
Xu W; Li Y; Yuan WW; Yin Y; Song WW; Wang Y; Huang QQ; Zhao WH; Wu JQ
Cell Physiol Biochem; 2018; 48(4):1793-1803. PubMed ID: 30078020
[TBL] [Abstract][Full Text] [Related]
5. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer.
Tesei A; Arienti C; Bossi G; Santi S; De Santis I; Bevilacqua A; Zanoni M; Pignatta S; Cortesi M; Zamagni A; Storci G; Bonafè M; Sarnelli A; Romeo A; Cavallo C; Bartolazzi A; Rossi S; Soriani A; Strigari L
J Exp Clin Cancer Res; 2021 Mar; 40(1):89. PubMed ID: 33673859
[TBL] [Abstract][Full Text] [Related]
6. Impaired Cdc20 signaling promotes senescence in normal cells and apoptosis in non-small cell lung cancer cells.
Volonte D; Sedorovitz M; Galbiati F
J Biol Chem; 2022 Oct; 298(10):102405. PubMed ID: 35988650
[TBL] [Abstract][Full Text] [Related]
7. Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations.
Peng S; Sen B; Mazumdar T; Byers LA; Diao L; Wang J; Tong P; Giri U; Heymach JV; Kadara HN; Johnson FM
Oncotarget; 2016 Jan; 7(1):565-79. PubMed ID: 26623721
[TBL] [Abstract][Full Text] [Related]
8. Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.
Lugo R; Gabasa M; Andriani F; Puig M; Facchinetti F; Ramírez J; Gómez-Caro A; Pastorino U; Fuster G; Almendros I; Gascón P; Davalos A; Reguart N; Roz L; Alcaraz J
Oncotarget; 2016 Dec; 7(50):82324-82337. PubMed ID: 27384989
[TBL] [Abstract][Full Text] [Related]
9. Role of cellular senescence in inflammatory lung diseases.
Xie C; Ya Likun MM; Luo QL; Dong JC
Cytokine Growth Factor Rev; 2023 Apr; 70():26-40. PubMed ID: 36797117
[TBL] [Abstract][Full Text] [Related]
10. Immune senescence in non-small cell lung cancer management: therapeutic relevance, biomarkers, and mitigating approaches.
Alexa-Stratulat T; Pavel-Tanasa M; Cianga VA; Antoniu S
Expert Rev Anticancer Ther; 2022 Nov; 22(11):1197-1210. PubMed ID: 36270650
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of extracellular vesicles as a senescence-associated secretory phenotype: Insights into the pathophysiology of lung diseases.
Kadota T; Fujita Y; Yoshioka Y; Araya J; Kuwano K; Ochiya T
Mol Aspects Med; 2018 Apr; 60():92-103. PubMed ID: 29146100
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 2 orchestrates a tumor suppressor response in non-small cell lung cancer.
Millar FR; Pennycuick A; Muir M; Quintanilla A; Hari P; Freyer E; Gautier P; Meynert A; Grimes G; Coll CS; Zdral S; Victorelli S; Teixeira VH; Connelly J; Passos JF; Ros MA; Wallace WAH; Frame MC; Sims AH; Boulter L; Janes SM; Wilkinson S; Acosta JC
Cell Rep; 2022 Nov; 41(6):111596. PubMed ID: 36351380
[TBL] [Abstract][Full Text] [Related]
13. ZFX knockdown inhibits growth and migration of non-small cell lung carcinoma cell line H1299.
Li K; Zhu ZC; Liu YJ; Liu JW; Wang HT; Xiong ZQ; Shen X; Hu ZL; Zheng J
Int J Clin Exp Pathol; 2013; 6(11):2460-7. PubMed ID: 24228108
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer effect of marchantin C via inducing lung cancer cellular senescence associated with less secretory phenotype.
Zhang XL; Ji XT; Sun B; Qian LL; Hu XL; Lou HX; Yuan HQ
Biochim Biophys Acta Gen Subj; 2019 Oct; 1863(10):1443-1457. PubMed ID: 31103748
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic Features of Advanced Squamous NSCLC.
Socinski MA; Obasaju C; Gandara D; Hirsch FR; Bonomi P; Bunn P; Kim ES; Langer CJ; Natale RB; Novello S; Paz-Ares L; Pérol M; Reck M; Ramalingam SS; Reynolds CH; Spigel DR; Stinchcombe TE; Wakelee H; Mayo C; Thatcher N
J Thorac Oncol; 2016 Sep; 11(9):1411-22. PubMed ID: 27296106
[TBL] [Abstract][Full Text] [Related]
16.
Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
[TBL] [Abstract][Full Text] [Related]
17. Senescence in head and neck squamous cell carcinoma: relationship between senescence-associated secretory phenotype (SASP) mRNA expression level and clinicopathological features.
Ostrowska K; Niewinski P; Piotrowski I; Ostapowicz J; Koczot S; Suchorska WM; Golusiński P; Masternak MM; Golusiński W
Clin Transl Oncol; 2024 Apr; 26(4):1022-1032. PubMed ID: 38175424
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
Chambers CR; Ritchie S; Pereira BA; Timpson P
Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib induces cellular senescence in A549 lung cancer cells by stimulating telomere shortening.
Wang L; Yin H; Huang S; Huang S; Huang C; Zhang Z; Liu H
Hum Exp Toxicol; 2022; 41():9603271221124094. PubMed ID: 36401358
[TBL] [Abstract][Full Text] [Related]
20. Senescence-associated secretory phenotype and its possible role in chronic obstructive pulmonary disease.
Kumar M; Seeger W; Voswinckel R
Am J Respir Cell Mol Biol; 2014 Sep; 51(3):323-33. PubMed ID: 25171460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
